Hippocampal connectivity and Alzheimer's dementia

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Neurology

• Publication date

  1994-11-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1212/WNL.44.11.2081PMID 7969963
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia.

  1994cited by this paper
• Regionally specific loss of neurons in the aging human hippocampus.

  1993cited by this paper
• Neuroanatomical connections and specific regional vulnerability in Alzheimer's disease.

  1993cited by this paper
• Lesions of the perirhinal and parahippocampal cortices in the monkey produce long-lasting memory impairment in the visual and tactual modalities

  1993cited by this paper
• Differential vulnerability, connectivity, and cell typology.

  1993cited by this paper
• Differing patterns of aberrant neuronal sprouting in Alzheimer's disease with and without Lewy bodies.

  1993cited by this paper
• The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system.

  1993cited by this paper
• Neuronal Networks of the Hippocampus

  1992cited by this paper
• Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

  1992cited by this paper
• Severity of Dementia in Alzheimer Disease and Neurofibrillary Tangles in Multiple Brain Regions

  1991cited by this paper
• Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease.

  1991cited by this paper
• Entorhinal cortex of the monkey: V. Projections to the dentate gyrus, hippocampus, and subicular complex

  1991cited by this paper
• The human nervous system

  1991cited by this paper
• Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

  1991cited by this paper
• Distribution of hippocampal CA1 and subicular efferents in the prefrontal cortex of the rat studied by means of anterograde transport of Phaseolus vulgaris‐leucoagglutinin

  1991cited by this paper
• Neurons, numbers and the hippocampal network.

  1990cited by this paper
• Quantitative immunohistochemistry of synaptophysin in human neocortex: an alternative method to estimate density of presynaptic terminals in paraffin sections.

  1990cited by this paper
• Stereological studies of the hippocampus: a comparison of the hippocampal subdivisions of diverse species including hedgehogs, laboratory rodents, wild mice and men.

  1990cited by this paper
• Comparison of spatial and temporal characteristics of neuronal activity in sequential stages of hippocampal processing.

  1990cited by this paper
• Similarities in circuitry between Ammon's horn and dentate gyrus: local interactions and parallel processing.

  1990cited by this paper
• Spatial organization of physiological activity in the hippocampal region: relevance to memory formation.

  1990cited by this paper
• Hippocampal formation: anatomy and the patterns of pathology in Alzheimer's disease.

  1990cited by this paper
• Connectivity of the rat hippocampus

  1989cited by this paper
• Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease.

  1989cited by this paper
• The three-dimensional organization of the hippocampal formation: a review of anatomical data.

  1989cited by this paper
• Diagnosis of Alzheimer's disease.

  1988cited by this paper
• Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold/silver intensification on vibratome sections: Coexistence with neuropeptide Y neurons, and effects alzheimer‐type dementia

  1987cited by this paper
• Perforant pathway changes and the memory impairment of Alzheimer's disease

  1986cited by this paper
• Diagnosis of Alzheimer's disease.

  1985cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.

  1984cited by this paper
• Advances in statistical methods for meta-analysis

  1984cited by this paper
• On problems in measuring change.

  1982cited by this paper
• Some morphometric aspects of the brain in senile dementia of the alzheimer type

  1981cited by this paper
• Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia

  1977cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• On the structure of the human archicortex

  1974cited by this paper
• The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects

  1968cited by this paper
• Alzheimer ' s Disease : Cell-Specific Pathology Isolates the Hippocampal Formation

  year unknowncited by this paper

• Epigenetic and Transcriptomic Alterations Precede Amyloidosis in the Hippocampus of the Alzheimer’s Disease AppNL-G-F Knock in Mouse Model

  2025cites this paper
• Epigenetic and transcriptomic alterations precede amyloidosis in the Alzheimer’s disease AppNL-G-F knock-in mouse model

  2025cites this paper
• Features of Mitochondrial Dynamics in Different Brain Parts of Patients with Alzheimer’s Disease

  2025cites this paper
• Robust Increase in IQCK Protein Expression in Mouse Models of Alzheimer's Disease and iPSC‐Derived Neurons

  2025cites this paper
• Potentialities of IGF-1 for regulating oxidative stress in neuroinflammation and neurodegeneration: theoretical review

  2024cites this paper
• Protective effects of L-arginine on Alzheimer's disease: Modulating hippocampal nitric oxide levels and memory deficits in aluminum chloride-induced rat model.

  2023cites this paper
• Hippocampus and its involvement in Alzheimer’s disease: a review

  2022cites this paper
• A Review of Brain-Targeted Nonviral Gene-Based Therapies for the Treatment of Alzheimer's Disease.

  2021cites this paper
• Tau pathology in the medial temporal lobe of athletes with chronic traumatic encephalopathy: a chronic effects of neurotrauma consortium study

  2019cites this paper
• Nanoparticle-mediated approaches for Alzheimer's disease pathogenesis, diagnosis, and therapeutics.

  2019cites this paper
• Astroglia in Alzheimer's Disease.

  2019cites this paper
• Critical appraisal of pathology transmission in the &agr;‐synuclein fibril model of Lewy body disorders

  2018cites this paper
• Implications of Successful Symptomatic Treatment in Parkinson's Disease for Therapeutic Strategies of Alzheimer's Disease.

  2018cites this paper
• Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer’s disease

  2018cites this paper
• Mitochondria-Targeted Molecules as Potential Drugs to Treat Patients With Alzheimer's Disease.

  2017cites this paper
• Chapter 2 Toxic Tau Aggregation in AD

  2017cites this paper
• Astroglia dynamics in ageing and Alzheimer's disease.

  2016cites this paper
• Astrocytes: a central element in neurological diseases

  2016cites this paper
• Astrocytes in physiological aging and Alzheimer's disease.

  2016cites this paper
• Modification of Tau by 8-Nitroguanosine 3′,5′-Cyclic Monophosphate (8-Nitro-cGMP)

  2016cites this paper
• Molecular Imaging in Alzheimer Clinical Trials

  2016cites this paper
• Truncated tau deregulates synaptic markers in rat model for human tauopathy

  2015cites this paper
• Acta Neuropathologica Astrocytes: a central element in neurological diseases

  2015cites this paper
• Toxic tau aggregation in AD.

  2015cites this paper
• Papel de la melotonina en la enfermedad de Alzheimer y otras enfermedades neurodegenerativas

  2015cites this paper
• Glial Asthenia and Functional Paralysis

  2015cites this paper
• Overexpression of Heme Oxygenase 1 Impairs Cognitive Ability and Changes the Plasticity of the Synapse

  2015cites this paper
• Therapeutical Implications of Melatonin in Alzheimer’s and Parkinson’s Diseases

  2015cites this paper
• COPS5 Protein Overexpression Increases Amyloid Plaque Burden, Decreases Spinophilin-immunoreactive Puncta, and Exacerbates Learning and Memory Deficits in the Mouse Brain*

  2015cites this paper
• Is synaptic loss a unique hallmark of Alzheimer's disease?

  2014cites this paper
• RanBP9 Overexpression Down-Regulates Phospho-Cofilin, Causes Early Synaptic Deficits and Impaired Learning, and Accelerates Accumulation of Amyloid Plaques in the Mouse Brain

  2014cites this paper
• Melatonin Therapy in Patients with Alzheimer’s Disease

  2014cites this paper
• Neurodegeneration and Neuroglia: Emphasis on Astroglia in Alzheimer’s Disease

  2014cites this paper
• Assessment of neuroprotective effects of gamma-hydroxybutyrate and neurosteroids on cellular models of Alzheimer’s disease

  2014cites this paper
• Donepezil inhibits the amyloid-beta oligomer-induced microglial activation in vitro and in vivo.

  2014cites this paper
• Neuritin Attenuates Cognitive Function Impairments in Tg2576 Mouse Model of Alzheimer's Disease

  2014cites this paper
• Alzheimer Disease: The Role of Aβ in the Glutamatergic System

  2014cites this paper
• Bombycis excrementum Reduces Amyloid-β Oligomer-Induced Memory Impairments, Neurodegeneration, and Neuroinflammation in Mice

  2014cites this paper
• A critical analysis of the 'amyloid cascade hypothesis'.

  2014cites this paper
• IMMUNOTHERAPY IN COMBINATION WITH BEHAVIORAL ENRICHMENT IN A CANINE MODEL OF AGING

  2014cites this paper
• Systemic Autoimmunity in TAM Triple Knockout Mice Causes Inflammatory Brain Damage and Cell Death

  2013cites this paper
• RanBP9 aggravates synaptic damage in the mouse brain and is inversely correlated to spinophilin levels in Alzheimer's brain synaptosomes

  2013cites this paper
• Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents.

  2013cites this paper
• Melatonin in Alzheimer’s Disease

  2013cites this paper
• Tauopathies and Tau Oligomers

  2013cites this paper
• La melatonina como un factor promotor de la diferenciación neuronal: implicaciones en el tratamiento de las demencias

  2013cites this paper
• Neurological diseases as primary gliopathies: a reassessment of neurocentrism

  2012cites this paper
• Positron Emission Tomography in Alzheimer Disease: Diagnosis and Use as Biomarker Endpoints

  2012cites this paper
• α‐Tocopherol regulates ectonucleotidase activities in synaptosomes from rats fed a high‐fat diet

  2012cites this paper
• Interaction of Endogenous Tau Protein with Synaptic Proteins Is Regulated by N-Methyl-d-aspartate Receptor-dependent Tau Phosphorylation*

  2012cites this paper
• Amyloid Hypothesis and Alzheimer's Disease

  2011cites this paper
• A putative role for PCSK9 in synaptic remodelling and plasticity in response to brain injury: implications for Alzheimer's disease

  2011cites this paper
• Tau aggregation is a therapeutic target for Alzheimer's disease.

  2010cites this paper
• Astrocytes in Alzheimer’s disease

  2010cites this paper
• Hippocampal CA1 apical neuropil atrophy in mild Alzheimer disease visualized with 7-T MRI

  2010cites this paper
• Mitochondrial Amyloid-β Levels are Associated with the Extent of Mitochondrial Dysfunction in Different Brain Regions and the Degree of Cognitive Impairment in Alzheimer's Transgenic Mice

  2010cites this paper
• Amyloid-β, Tau, and Dementia

  2009cites this paper
• Increased Proliferation and Gliogenesis of Cultured Rat Neural Progenitor Cells by Lipopolysaccharide-Stimulated Astrocytes

  2009cites this paper
• The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism.

  2008cites this paper
• Fatty acids, lipid metabolism and Alzheimer pathology.

  2008influential citation
• Hyperphosphorylated Tau is a Cause of Neuronal Dysfunction in Tauopathy

  2008cites this paper
• Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment

  2007cites this paper
• The resistance to depressive relapse in menopausal women undergoing tryptophan depletion: preliminary findings

  2007cites this paper
• Microtubule-stabilizing agent prevents protein accumulation-induced loss of synaptic markers.

  2007cites this paper
• Neural network dysfunction in Alzheimer's disease: a drug development perspective.

  2007cites this paper
• Synaptic remodeling during aging and in Alzheimer's disease

  2006cites this paper
• Synaptic Pathology in Dementia

  2006cites this paper
• Étude des mécanismes moléculaires impliqués dans la mort neuronale induite par le peptide de ß-amyloïde soluble : recherche et validation fonctionnelle de cibles cellulaires

  2006cites this paper
• Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment.

  2006cites this paper
• Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience

  2006cites this paper
• Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models.

  2006cites this paper
• Plaques and tangles and the pathogenesis of Alzheimer's disease.

  2006cites this paper
• Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia

  2005cites this paper
• Effect of apolipoprotein E deficiency on reactive sprouting in the dentate gyrus of the hippocampus following entorhinal cortex lesion: role of the astroglial response.

  2005cites this paper
• Cellular Responses to Protein Accumulation Involve Autophagy and Lysosomal Enzyme Activation

  2005cites this paper
• Precursor form of brain‐derived neurotrophic factor and mature brain‐derived neurotrophic factor are decreased in the pre‐clinical stages of Alzheimer's disease

  2005influential citation
• A focus on the synapse for neuroprotection in Alzheimer disease and other dementias

  2004cites this paper
• Hippocampal damage in mouse and human forms of systemic autoimmune disease

  2004cites this paper
• Cycles of Aberrant Synaptic Sprouting and Neurodegeneration in Alzheimer's and Dementia with Lewy Bodies

  2003cites this paper
• The Role of Aβ-Peptide on Spatial Memory, EEG, Auditory Evoked Potentials And Nicotinic Cholinergic Receptors in A/P Transgenic Mice

  2003cites this paper
• Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies.

  2003cites this paper
• Lysosomal Activation Is a Compensatory Response Against Protein Accumulation and Associated Synaptopathogenesis—An Approach for Slowing Alzheimer Disease?

  2003cites this paper
• Detection and Analysis of Synaptosis

  2002cites this paper
• The role of ovarian hormones in preserving cognition in aging

  2002cites this paper
• Intracellular Deposition, Microtubule Destabilization, and Transport Failure: An “Early” Pathogenic Cascade Leading to Synaptic Decline

  2002cites this paper
• Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia

  2001cites this paper
• Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study

  2000cites this paper
• Psychotic Symptoms in Alzheimer's Disease Are Not Associated With More Severe Neuropathologic Features

  2000cites this paper
• SB203580, the p38 mitogen-activated protein kinase inhibitor blocks the inhibitory effect of beta-amyloid on long-term potentiation in the rat hippocampus.

  2000cites this paper
• Role of apolipoprotein E and estrogen in mossy fiber sprouting in hippocampal slice cultures.

  1999cites this paper
• Frontal cortex contributes to human memory formation

  1999cites this paper
• DNA strand breaks in Alzheimer's disease.

  1999cites this paper
• Phenotypic down-regulation of glutamate receptor subunit GluR1 in Alzheimer's disease.

  1999cites this paper
• Neuropathological Correlates of Dementia in Alzheimer’s Disease

  1999cites this paper
• Synaptic loss reflected by secretoneurin‐like immunoreactivity in the human hippocampus in Alzheimer's disease

  1998cites this paper
• The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease.

  1998cites this paper
• Epileptic negative myoclonus

  1998cites this paper
• Synaptic density in the inner molecular layer of the hippocampal dentate gyrus in Alzheimer disease.

  1998cites this paper
• The relation between dementia and direct involvement of the hippocampus and amygdala in PD

  1998cites this paper
• Mutant genes in familial Alzheimer's disease and transgenic models.

  1998cites this paper